Avidity Biosciences

Avidity Biosciences

Avidity Biosciences

Avidity Biosciences is a privately held biotech Company.
Suggest edits
Founded
2013
Raised
$40.1M
Follow us
Companies in the same industry
Alexa global traffic share
Terms of Service Privacy Policy Cookie Statement
Built with ❤︎ by Datalicious ©2022
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 5

Add info
Add round
22 Apr 2019
$15,000,000
Venture capital
Eli Lilly
17 Oct 2018
Undisclosed funding
CureDuchenne

Avidity Biosciences Receives Equity Investment from CureDuchenne

FinSMEs
05 Jan 2017
$10,000,000
Venture capital (Series B)
EcoR1 Capital, Moore Venture Partners, F-Prime Capital Partners, +5

Avidity Biosciences Raises 16 Million In Series B Financing To Advance Antibody Sirna Conjugate Platform

biospace
+2
07 Oct 2014
$6,000,000
Venture capital (Series B)
TPG Biotech, F-Prime Capital Partners, Partner Fund Management, +1

Avidity NanoMedicines racks up $6 mln

PE Hub
18 Feb 2014
$9,070,000
Venture capital (Series A)